Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature

Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies

(2014) R Roy et al.   BRITISH JOURNAL OF CANCER

Netrin-1 Promotes Medulloblastoma Cell Invasiveness and Angiogenesis, and Demonstrates Elevated Expression in Tumor Tissue and Urine of Patients with Pediatric Medulloblastoma

(2014) T. Akino et al.   CANCER RESEARCH

A bi-modal function of Wnt signalling directs an FGF activity gradient to spatially regulate neuronal differentiation in the midbrain

(2013) C. Dyer et al.   DEVELOPMENT

Distinct roles for fibroblast growth factor signaling in cerebellar development and medulloblastoma

(2012) B A Emmenegger et al.   ONCOGENE

Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels

(2011) Christine M. Coticchia et al.   GYNECOLOGIC ONCOLOGY

Identification of Potential Serum Biomarkers of Glioblastoma: Serum Osteopontin Levels Correlate with Poor Prognosis

(2010) P. Sreekanthreddy et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms

(2010) José Javier Otero et al.   JOURNAL OF NEURO-ONCOLOGY

Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer

(2009) Roopali Roy et al.   JOURNAL OF CLINICAL ONCOLOGY

The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain

(2009) G. Mudò et al.   JOURNAL OF NEURAL TRANSMISSION

Urinary Metalloproteinases: Noninvasive Biomarkers for Breast Cancer Risk Assessment

(2008) S. E. Pories et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy

(2008) E. R. Smith et al.   CLINICAL CANCER RESEARCH

Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase Species

(2008) R. Roy et al.   CLINICAL CANCER RESEARCH